Strategy

We invest primarily in early-stage innovative and disruptive technologies with well-rounded teams and scalable business models. We have a preference for “deep tech” projects and we have experience in web 3.0 (blockchain), space tech, cybersecurity, big data & analytics, SaaS, among others.

We call our Digital Technology funds “Inveready First”, as we aim to be the first institutional investor in a company, and we strive to support our portfolio companies to their Series A.

We invest primarily in early-stage and Series A drug development companies that have an in vivo efficacy proof of concept and initial toxicology.

We also invest in in pre-comercial and comercial-stage Bioprocesing, Medtech and consumer Health companies.

We invest in seed to Series A-B companies that have strong credit profiles and significant equity upside. We like to co-invest alongside equity funds to lever the returns potential, but also transacting in pure financing rounds.

Although we are sector agnostic, our investments are generally in high growth, innovative companies that benefit from the reduced dilution that our financing offers by combining debt with equity remuneration.

We invest through equity or hybrid equity structures in public companies in European alternative stock markets, such as BME Growth, Euronext Growth, AIM, etc. We seek to fund expansion projects or M&A, as well as providing liquidity for existing and prospective shareholders.

We are sector agnostic, and our investments tend to benefit all stakeholders in a company due to our reduced dilution via a vis a standard equity transaction.

At GAEA Inversión, we invest in solid companies with long track record of growth and profitability and that are searching for financing to expand organically, M&A or shareholder renewal.

We offer a flexible investment strategy adapting to the needs of each stakeholder: management, shareholders, potential partners, etc.

We invest in telecom infrastructure assets, by providing asset operators with off balance sheet financing by acquiring the tangible or intangible ownership of strategic operational infra assets with long term contracts and minimum remuneration for the fund.

Although we can transact in 3 sectors, we are primarily investing in telecom assets, mainly land fibre or cable assets.

We are pioneers in the design and execution of co-financing instruments through Economic Interest Groupings (AIEs) that offer strong returns in a transparent legislation. While investors receive tax incentives consisting of deductions for R&D, companies receive up to 38% of the annual R&D back.

We operate mainly in the biotech sector, and our structure is based on third party legal opinions and a binding consultation with the Treasury, as well as with an external certification scheme for the assumed R&D expenses.

Inveready Evergreen S.C.R. S.A.
The investment vehicle of the Inveready Group, investing in companies and financial assets, including the participation in Venture Capital entities.

Inveready Civilon, S.C.R.
Secondary fund managing Venture Capital and Private Equity assets